Life-long overexpression of S100β in Down's syndrome: Implications for Alzheimer pathogenesis

Neurobiology of Aging

Volumn 19, Issue 5, 1998, Pages 401-405

  Griffin, W S T ^a,b,k   Sheng, J G ^b,i   Mckenzie, J E ^h   Royston, M C ^j   Gentleman, S M ^h   Brumback, R A ^d   Cork, L C ^e   Del Bigio, M R ^f   Roberts, G W ^g   Mrak, R E ^a,c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d UNIVERSITY OF OKLAHOMA   (United States)

^e STANFORD UNIVERSITY   (United States)

^f TORONTO WESTERN HOSPITAL   (Canada)

^g Opine Consultancy   (United Kingdom)

^h IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

ⁱ SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^j PETERBOROUGH CITY HOSPITAL   (United Kingdom)

^k CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

more..

Author keywords

Amyloid precursor protein; Aging; Alzheimer's disease; Developing brain; Down's syndrome; S100 ; Tau2

Indexed keywords

AMYLOID BETA PROTEIN; NERVE GROWTH FACTOR; PROTEIN S 100;

ADOLESCENT; ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CHILD; CONTROLLED STUDY; DOWN SYNDROME; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PATHOGENESIS; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ASTROCYTES; BRAIN; BRAIN CHEMISTRY; CELL COUNT; CHILD; CHILD, PRESCHOOL; DOWN SYNDROME; FETUS; HUMANS; INFANT; MIDDLE AGED; NEURONS; S100 PROTEINS; TAU PROTEINS;

EID: 0032410663     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(98)00074-8     Document Type: Article

References (22)

1. Allore, R.; O'Hanlon, D.; Price, R.; Neilson, K.; Willard, H. F.; Cox, D. R.; Marks, A.; Dunn, R. J. Gene encoding the β subunit of S100 protein is on chromosome 21: Implications for Down syndrome. Science 239:1311-13; 1988.
2. Barger, S. W.; Van Eldik, L. J. S100β stimulates calcium fluxes in glial and neuronal cells. J. Biol. Chem. 267:9689-9694; 1992.
3. Bhattacharyya, A.; Oppenheim, R. W.; Prevette, D.; Moore, B. W.; Brackenbury R.; Ratner, N. S100 is present in developing chicken neurons and Schwann cells and promotes neuron survival in vivo. J. Neurobiol. 23:451-466; 1992.
4. Cork, L. Neuropathology of Down syndrome and Alzheimer disease. Am. J. Med. Gen. 7:282-286; 1990.
5. da Cunha, A.; Jefferson, J. J.; Tyor, W. R.; Glass, J. D.; Jannotta, F. S.; Vitkovic, L. Gliosis in human brain: Relationship to size but not other properties of astrocytes. Brain Res. 600:161-165; 1993.
6. Ferrer, I.; Gullotta, F. Down's syndrome and Alzheimer's disease: Dendritic spine counts in the hippocampus. Acta Neuropathol. 79: 680-685; 1990.
7. Griffin, W. S. T.; Stanley, L. C.; Ling, C.; White, L.; MacLeod, V.; Perrot, L. J.; White, C. L., III; Araoz, C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA 86:7611-7615; 1989.
8. Griffin, W. S. T.; Sheng, J. G.; Royston, M. C.; Gentleman, S. M.; McKenzie, J. E.; Graham, D. I.; Roberts, G. W.; Mrak, R. E. Glial-neuronal interactions in Alzheimer's disease: The potential role of a 'Cytokine Cycle' in disease progression. Brain Pathol. 8:65-72; 1998.
9. Hyman, B. T. Down syndrome and Alzheimer disease. Prog. Clin. Biol. Res. 379:123-142; 1992.
10. Kligman, D.; Marshak, D. R. Purification and characterization of a neurite extension factor from bovine brain. Proc. Natl. Acad. Sci. USA 82:7136-39; 1985.
11. Marshak, D. R.; Pesce, S. A.; Stanley, L. C.; Griffin, W. S. T. Increased S100β neurotrophic activity in Alzheimer's disease temporal lobe. Neurobiol. Aging 13:1-7; 1992.
12. Mrak, R. E.; Sheng; J. G.; Griffin, W. S. T. Glial cytokines in Alzheimer's disease: Review and pathogenic implications. Human Pathol. 26:816-823; 1995.
13. Mrak, R. E.; Sheng; J. G.; Griffin, W. S. T. Correlation of astrocytic S100β expression with dystrophic neurites in amyloid plaques of Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55:273-279; 1996.
14. Purpura, D. P. Pathobiology of cortical neurons in metabolic and unclassified amentias. In: Katzman, R., ed. Congenital and Acquired Cognitive Disorders. New York: Raven Press; 1979:43-68.
15. Rumble, B.; Retallack, R.; Hilbich, C.; Simms, G.; Multhaup, G.; Martins, R.; Hockey, A.; Montgomery, P.; Beyreuther, K.; Masters, C. L. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N. Engl. J. Med. 320:1446-1452; 1989.
16. Sarnat, H. B. Regional differentiation of the human fetal ependyma: Immunocytochemical markers. J. Neuropathol. Exp. Neurol. 51:58-75; 1992.
17. Sheng, J. G.; Mrak, R. E.; Griffin, W. S. T. S100β protein expression in Alzheimer' s disease: Potential role in the pathogenesis of neuritic plaques. J. Neurosci. Res. 39:398-403; 1994.
18. Sheng, J. G.; Mrak, R. E.; Rovnaghi, C. R.; Kozlowska, E.; Van Eldik, L. J.; Griffin, W. S. T. Human brain S100β and S100β mRNA expression increases with age: Pathogenic implications for Alzheimer's disease. Neurobiol. Aging 17:359-363; 1996.
19. + astrocytes with neurofibrillary tangle stages. J. Neuropathol. Exp. Neurol. 56:285-290; 1997.
20. Soininen, H.; Partanen, J.; Jousmaki, V.; Helkala, E. L.; Vanhanen, M.; Majuri, S.; Kaski, M.; Hartikainen, P.; Riekkinen, P., Sr. Age-related cognitive decline and electroencephalogram slowing in Down's syndrome as a model of Alzheimer's disease. Neurosci. 53:57-63; 1993.
21. Van Eldik, L. J.; Griffin, W. S. T. S100β expression in Alzheimer's disease: Relation to neuropathology in brain regions. Biochim. Biophys. Acta 39:398-404; 1994.
22. Wisniewski, K. E.; Wisniewski, H. M.; Wen, G. Y. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann. Neurol. 17:278-282; 1985.